← Evidence map

ReviewDiabetes, obesity & metabolism2017

Combination therapy with GLP-1 receptor agonist and SGLT2 inhibitor.

Ralph A DeFronzoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

90 papers cite itlatest 60 shown

2017
…
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

NCT07566299118,805 enrolled2017
Full record →Abstract, authors, funding and every citing paper · PMID 28432726